Introduction to pharmaceutical biotechnology. (Record no. 68479)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 12024nam a2200841 i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 9780750353878 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | IOP |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20251030124829.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m eo d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cn |||m|||a |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 241003s2024 enka fob 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780750353878 |
| Qualifying information | ebook |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780750353861 |
| Qualifying information | mobi |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9780750353854 |
| Qualifying information | |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9780750353885 |
| Qualifying information | myPrint |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1088/978-0-7503-5387-8 |
| Source of number or code | doi |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaBNVSL)thg00083985 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1458668809 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | CaBNVSL |
| Language of cataloging | eng |
| Description conventions | rda |
| Transcribing agency | CaBNVSL |
| Modifying agency | CaBNVSL |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RS380 |
| Item number | .B535 2024eb vol. 2 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
| Classification number | QV 778 |
| Item number | B575i 2024eb vol. 3 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | TCB |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED009000 |
| Source | bisacsh |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Al-Harrasi, Ahmed, |
| Relator term | author. |
| 9 (RLIN) | 96990 |
| 245 1# - TITLE STATEMENT | |
| Title | Introduction to pharmaceutical biotechnology. |
| Number of part/section of a work | Volume 2, |
| Name of part/section of a work | Enzymes, proteins and bioinformatics / |
| Statement of responsibility, etc. | Ahmed Al-Harrasi, Saurabh Bhatia, Ajmal Khan. |
| 246 3# - VARYING FORM OF TITLE | |
| Title proper/short title | Enzymes, proteins and bioinformatics. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | Second edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Bristol [England] (Temple Circus, Temple Way, Bristol BS1 6HG, UK) : |
| Name of producer, publisher, distributor, manufacturer | IOP Publishing, |
| Date of production, publication, distribution, manufacture, or copyright notice | [2024] |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (various pagings) : |
| Other physical details | illustrations (some color). |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | electronic |
| Source | isbdmedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | [IOP release $release] |
| 490 1# - SERIES STATEMENT | |
| Series statement | IOP ebooks. [2024 collection] |
| 500 ## - GENERAL NOTE | |
| General note | "Version: 20240901"--Title page verso. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 3. Industrial enzymes and their applications -- 3.1. Industrial enzymes -- 3.2. Bacterial [alpha]-amylases -- 3.3. Fungal [alpha]-amylases -- 3.4. Bacterial proteases -- 3.5. Fungal proteases -- 3.6. Glucose isomerase (d-xylose ketol-isomerase; EC. 5.3.1.5) -- 3.7. Penicillinase -- 3.8. Chloramphenicol acetyltransferase -- 3.9. Aminoglycoside antibiotic inactivating enzymes -- 3.10. Fibrinolytic enzymes -- 3.11. Biotechnological applications of enzymes -- 3.12. Industrial enzymes -- 3.13. The role of enzymes in the synthesis of functional foods -- 3.14. Enzymes used as additives to food |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 4. Immobilization of enzymes -- 4.1. Introduction -- 4.2. Types of immobilization -- 4.3. Genetic engineering for microbial enzyme production -- 4.4. Protein studies for modification of commercial enzymes -- 4.5. Enzyme and cell immobilization -- 4.6. Immobilization methods -- 4.7. Choice of immobilization technique -- 4.8. Immobilization of cells -- 4.9. Manufacture of commercial products -- 4.10. Immobilized enzymes for biomedical applications -- 4.11. Detecting biomass with immobilized cells via bioluminescence and other biosensor uses -- 4.12. Bioluminescence-based microbial biosensors -- 4.13. Immobilization of microalgae |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 5. Biosensors -- 5.1. Introduction -- 5.2. Principles of a biosensor -- 5.3. Different types of biosensors -- 5.4. Applications of biosensors -- 5.5. Recent advancements in biosensor technology -- 5.6. Microbial biosensors utilizing synthetic biology and genetic/protein engineering techniques -- 5.7. Technological comparison of biosensors -- 5.8. Prospective challenges, and inherent limitations associated with biosensor technology -- 5.9. Grand challenges in biosensors and biomolecular electronics -- 5.10. The Implementation and commercialization of biosensing devices |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 6. Biotransformation and enzymes -- 6.1. Introduction -- 6.2. Types of biotransformation reactions -- 6.3. Sources of biocatalysts and techniques for biotransformation -- 6.4. Product recovery in biotransformations -- 6.5. Application of biotransformation in the production of pharmaceutical products -- 6.6. Mechanisms of enzyme action in biotransformation -- 6.7. Biotransformation in environmental applications -- 6.8. Emerging technologies in biotransformation -- 6.9. Biotransformation challenges and future perspectives |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 7. Introduction to genomics -- 7.1. Introduction -- 7.2. Characterizations in genomics -- 7.3. Historical background -- 7.4. Genome sequencing -- 7.5. Understanding bioinformatics and sequencing -- 7.6. Comparative genomics as a technique to understand evolution -- 7.7. Gene estimation and counting -- 7.8. Genomes : genome evolution -- 7.9. Algae bioinformatics -- 7.10. Functional genomics -- 7.11. Structural genomics -- 7.12. Epigenomics and epigenetics -- 7.13. Pharmacogenomics -- 7.14. Population genomics -- 7.15. Microbiome genomics -- 7.16. Synthetic biology and genome editing -- 7.17. Systems biology and genomics -- 7.18. Genome-wide association studies (GWAS) -- 7.19. Future of genomics |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 8. Basics of proteomics -- 8.1. Introduction -- 8.2. Types of proteomics -- 8.3. Basic techniques involved in proteomics -- 8.4. Complete proteome of Mycoplasma genitalium -- 8.5. Architecture and design of the nuclear pore complex -- 8.6. Functional genomics and systems biology -- 8.7. Synthetic genomics -- 8.8. Advanced techniques in proteomics -- 8.9. Proteogenomics -- 8.10. Single-cell proteomics -- 8.11. Clinical and diagnostic proteomics -- 8.12. Metaproteomics -- 8.13. Emerging topics in proteomics -- 8.14. Ethical and data management issues in proteomics -- 8.15. Cellular and molecular dynamics -- 8.16. Membrane proteomics -- 8.17. Subcellular proteomics |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 9. Bioinformatics -- 9.1. Introduction -- 9.2. History of bioinformatics -- 9.3. Sequences and nomenclature -- 9.4. Investigation by means of bioinformatics tools -- 9.5. Computational approaches in bioinformatics -- 9.6. Bioinformatics in precision medicine -- 9.7. Translational bioinformatics -- 9.8. Bioinformatics in drug discovery and development -- 9.9. CRISPR and genome editing in bioinformatics -- 9.10. Integrative and multi-omics analysis |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 10. Protein and enzyme engineering -- 10.1. Protein and enzyme engineering -- 10.2. Designing macromolecules -- 10.3. Protein engineering versus enzyme engineering -- 10.4. Protein engineering -- 10.5. Foundation of protein (enzyme) engineering -- 10.6. Basic assumptions for protein engineering -- 10.7. Steps involved in protein engineering -- 10.8. Methods of protein engineering -- 10.9. Mutagenesis and selection of mutant enzymes -- 10.10. Gene modifications or gene synthesis for protein engineering -- 10.11. Multi-enzyme systems -- 10.12. Chemical modification of enzyme -- 10.13. Some early achievements of protein engineering -- 10.14. Computational approaches in protein engineering -- 10.15. Directed evolution techniques -- 10.16. Post-translational modifications -- 10.17. Structural flexibility and allosteric regulation -- 10.18. Protein-protein and protein-ligand interactions -- 10.19. Applications in synthetic biology -- 10.20. Engineering multi-functional proteins -- 10.21. Ethical and safety considerations -- 10.22. Studies in protein engineering -- 10.23. Single-molecule techniques in protein engineering -- 10.24. High throughput screening methods -- 10.25. Protein engineering for nanotechnology. |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 1. Introduction to enzymes and their applications -- 1.1. Introduction -- 1.2. Properties of enzymes -- 1.3. Catalysis -- 1.4. The structure of enzymes -- 1.5. Structural features : primary and secondary structures -- 1.6. Nomenclature and classification -- 1.7. The mechanism of action of enzymes -- 1.8. Catalysis via chymotrypsin -- 1.9. Enzyme inhibition -- 1.10. Pharmaceutical applications -- 1.11. Plants and algae enzyme systems -- 1.12. Enzyme safety -- 1.13. Enzyme structure determination -- 1.14. Enzyme engineering and design -- 1.15. Enzymes in medicine and healthcare -- 1.16. Enzymes in bioremediation -- 1.17. Enzymes in agriculture and crop production -- 1.18. Enzymes in waste management |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 2. Technologies and procedures involved in enzyme production -- 2.1. Introduction -- 2.2. Enzyme production technology -- 2.3. Procedures involved in enzyme production -- 2.4. Recombinant proteins from algae -- 2.5. Enzyme immobilization techniques -- 2.6. Enzyme engineering for enhanced stability and activity -- 2.7. Upstream process intensification -- 2.8. Enzyme production from extreme environments -- 2.9. Downstream process intensification |
| 506 ## - RESTRICTIONS ON ACCESS NOTE | |
| Terms governing access | Full-text restricted to subscribers or individual document purchasers. |
| 520 3# - SUMMARY, ETC. | |
| Summary, etc. | This book offers a detailed examination of biotransformation and enzymes, focusing on their crucial roles in biology and biotechnology. It is intended for students, researchers, and professionals who are interested in understanding the biochemical processes by which organisms metabolize various compounds and how enzymes facilitate these processes. The book's primary aim is to provide a clear connection between theoretical concepts and their practical applications, showcasing biotransformation as an essential tool for developing sustainable solutions in pharmaceuticals, environmental management, and industrial practices. It comprehensively covers various biotransformation reactions, highlighting their importance in producing valuable products, detoxifying substances, and minimizing waste. |
| 521 ## - TARGET AUDIENCE NOTE | |
| Target audience note | Scientists, researchers and practitioners in pharmaceutical biotechnology, biotechnology and biopharmaceuticals. |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE | |
| Additional physical form available note | Also available in print. |
| 538 ## - SYSTEM DETAILS NOTE | |
| System details note | Mode of access: World Wide Web. |
| 538 ## - SYSTEM DETAILS NOTE | |
| System details note | System requirements: Adobe Acrobat Reader, EPUB reader, or Kindle reader. |
| 545 ## - BIOGRAPHICAL OR HISTORICAL DATA | |
| Biographical or historical data | Ahmed Al-Harrasi is a professor of organic chemistry and the vice chancellor for graduate studies, research and external relations at the University of Nizwa. He obtained his BSc in Chemistry from SQU and his MSc and PhD in Organic Chemistry from Free University of Berlin as a DAAD-fellow. Then he received the Fulbright award in 2008 for postdoctoral research in Chemical Biology from Cornell University. He is a founder and chair of the Natural and Medical Sciences Research Center. He is a member of the Scientific Council of UNESCO. He was named on the list of top 2% Scientists for the last three years. He has authored over 800 scientific papers and more than 20 books and book chapters. He received the Order of Royal Commendation from His Majesty, The Sultan of Oman as an outstanding Omani individual for his remarkable contribution and active role in research. Saurabh Bhatia is an Associate Professor within the Natural and Medical Sciences Research Centre at the University of Nizwa, Oman. He has published 79 referred journal articles and written 94 book chapters. Dr. Bhatia has also authored 10 books and is the Associate Editor on four international journals. Ajmal Khan is currently working as an Associate Professor in Natural and Medical Sciences Research Centre at the University of Nizwa, Oman. Dr. Khan published more than 450 articles in international peer review journals with impact factor of more than 2000 and citation more than 9000. Besides this, he has published two US patents, and three books and 13 books chapters. Dr. Khan is Associate Editor for four journals and on the editorial board of three international journals. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Title from PDF title page (viewed on October 3, 2024). |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 65164 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 65166 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 65162 |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 65162 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| Source of heading or term | bicssc |
| 9 (RLIN) | 65162 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| Source of heading or term | bisacsh |
| 9 (RLIN) | 63891 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bhatia, Saurabh, |
| Relator term | author. |
| 9 (RLIN) | 96991 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Khan, Ajmal |
| Titles and other words associated with a name | (Ph. D. in biochemistry), |
| Relator term | author. |
| 9 (RLIN) | 96992 |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | Institute of Physics (Great Britain), |
| Relator term | publisher. |
| 9 (RLIN) | 17702 |
| 776 #8 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| International Standard Book Number | 9780750353854 |
| -- | 9780750353885 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | IOP (Series). |
| Name of part/section of a work | Release 24. |
| 830 ## - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | IOP ebooks. |
| Name of part/section of a work | 2024 collection. |
| 856 4# - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://iopscience.iop.org/book/mono/978-0-7503-5387-8">https://iopscience.iop.org/book/mono/978-0-7503-5387-8</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | |
No items available.